Learn the symptoms of bladder cancer —blood in the urine, pain, and irritation or obstruction when urinating —and when to see a healthcare provider.

Researchers at UW’s School of Medicine and the Institute for Research in Biomedicine Barcelona may have found an additional ...

Circulating tumour DNA-guided adjuvant atezolizumab prolongs disease-free and overall survival in patients with ...

Results presented by AstraZeneca from its phase 3 trial of Imfinzi in patients with high-risk, non-muscle invasive bladder ...

Patients with muscle-invasive bladder cancer have varied outcomes after cystectomy. Circulating tumor DNA (ctDNA)–based ...

The "Bladder Cancer Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering.The market's growth is primarily driven by the rising ...

Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients ...

The combination of Merck’s Keytruda and Pfizer and Astellas’ Padcev reduced patients' risk of death by a whopping 50% when used before and after bladder removal surgery in those with MIBC who are not ...

Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

Eli Lilly And Company ((LLY)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take ...

What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...

Deion Sanders said he thinks has more blood clots due to experiencing leg pain after recently being treated for bladder cancer.